Screener
Bio-Techne TECH Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | Nine Months Ended / March 31, 2026 | Nine Months Ended / March 31, 2025 |
|---|---|---|
| Trade accounts payable, accrued expenses, contract liabilities, and other | (2,953) | (639) |
| Salaries, wages and related accruals | (11,199) | 12,006 |
| Income taxes payable | (13,037) | (7,912) |
| Net cash provided by (used in) operating activities | 196,657 | 189,355 |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Proceeds from sale of available-for-sale investments | — | 1,085 |
| Additions to property and equipment | (20,370) | (26,116) |
| Distributions from Wilson Wolf | 4,620 | 2,653 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's operating cash flow?
- Bio-Techne (TECH) reported operating cash flow of $86.66M in Q1 2026.
- How has Bio-Techne's operating cash flow changed year-over-year?
- Bio-Techne's operating cash flow increased by 110.8% year-over-year, from $41.12M to $86.66M.
- What is the long-term trend for Bio-Techne's operating cash flow?
- Over 3 years (2022 to 2025), Bio-Techne's operating cash flow has grown at a -4.0% compound annual growth rate (CAGR), from $325.27M to $287.56M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Bio-Techne's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude